Campbell Bruce Mousseau, Alena R Veigl-Lunsford, Rhonda L Pitsch, Sean W Harshman
{"title":"A Comparison of Emotionally Stimulated and Conventionally Collected Tears Using Bottom-Up, Label-Free Quantitative Proteomic Analysis-A Pilot Study.","authors":"Campbell Bruce Mousseau, Alena R Veigl-Lunsford, Rhonda L Pitsch, Sean W Harshman","doi":"10.1002/prca.70023","DOIUrl":null,"url":null,"abstract":"<p><p>Proteomic analysis of biofluids is central for identifying disease biomarkers. Tears have become popular targets for biomarker discovery and biosensor development, largely because they can be collected noninvasively and are rich sources of biomarkers for ocular and systemic diseases. Although basal and reflex tears have been well characterized, the proteome of psycho-emotionally stimulated tears remains largely unexplored, hindering their applicability in biomarker discovery studies and the advancement of tear-based biosensors. Comprehensive proteomic analysis across different tear types is crucial for identifying novel biomarkers and improving disease diagnosis and monitoring. In this pilot study, tears collected via conventional stimulation techniques (\"standard\") versus those elicited through emotional stimuli (\"emotional\") were purchased from single donors through two vendors. We compared the proteomic profiles of emotional (n = 6) and standard (n = 14) single donor human tears to better understand the biochemical composition and functional roles of different tear types. In total, 907 proteins were identified from all tear samples. Fifty-two tear proteins were significantly enriched in emotionally stimulated tears. Functional characterization of enriched proteins revealed that most were extracellular or secreted. Many were also involved in host defense or immune responses, including members of the S100A and neutrophil defensin protein families. SUMMARY: Although emotional tears are known to differ from basal and reflex tears in both composition and function, the specific biochemical characteristics and functional roles of emotional tears remain poorly understood. This gap in knowledge is largely due to the limited research conducted on emotional tears, despite their distinct origins. A more complete understanding of all tear types is necessary for the continuation of biomarker discovery and the development of tear fluid-based biosensors. In this exploratory study, tears collected via a conventional/standard protocol and those collected from emotional stimulus were obtained from two vendors and subjected to proteomic profiling and comparison. A bottom-up proteomic approach was utilized to analyze tear samples, facilitating a comparison between tear types and contributing to the characterization of psycho-emotional tears.</p>","PeriodicalId":20571,"journal":{"name":"PROTEOMICS – Clinical Applications","volume":" ","pages":"e70023"},"PeriodicalIF":2.5000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PROTEOMICS – Clinical Applications","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1002/prca.70023","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Proteomic analysis of biofluids is central for identifying disease biomarkers. Tears have become popular targets for biomarker discovery and biosensor development, largely because they can be collected noninvasively and are rich sources of biomarkers for ocular and systemic diseases. Although basal and reflex tears have been well characterized, the proteome of psycho-emotionally stimulated tears remains largely unexplored, hindering their applicability in biomarker discovery studies and the advancement of tear-based biosensors. Comprehensive proteomic analysis across different tear types is crucial for identifying novel biomarkers and improving disease diagnosis and monitoring. In this pilot study, tears collected via conventional stimulation techniques ("standard") versus those elicited through emotional stimuli ("emotional") were purchased from single donors through two vendors. We compared the proteomic profiles of emotional (n = 6) and standard (n = 14) single donor human tears to better understand the biochemical composition and functional roles of different tear types. In total, 907 proteins were identified from all tear samples. Fifty-two tear proteins were significantly enriched in emotionally stimulated tears. Functional characterization of enriched proteins revealed that most were extracellular or secreted. Many were also involved in host defense or immune responses, including members of the S100A and neutrophil defensin protein families. SUMMARY: Although emotional tears are known to differ from basal and reflex tears in both composition and function, the specific biochemical characteristics and functional roles of emotional tears remain poorly understood. This gap in knowledge is largely due to the limited research conducted on emotional tears, despite their distinct origins. A more complete understanding of all tear types is necessary for the continuation of biomarker discovery and the development of tear fluid-based biosensors. In this exploratory study, tears collected via a conventional/standard protocol and those collected from emotional stimulus were obtained from two vendors and subjected to proteomic profiling and comparison. A bottom-up proteomic approach was utilized to analyze tear samples, facilitating a comparison between tear types and contributing to the characterization of psycho-emotional tears.
期刊介绍:
PROTEOMICS - Clinical Applications has developed into a key source of information in the field of applying proteomics to the study of human disease and translation to the clinic. With 12 issues per year, the journal will publish papers in all relevant areas including:
-basic proteomic research designed to further understand the molecular mechanisms underlying dysfunction in human disease
-the results of proteomic studies dedicated to the discovery and validation of diagnostic and prognostic disease biomarkers
-the use of proteomics for the discovery of novel drug targets
-the application of proteomics in the drug development pipeline
-the use of proteomics as a component of clinical trials.